A Phase II Study of Daratumumab in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma Who Received One Prior Line of Therapy (KMM1906). - Yoo, Kwai Han; Yoon, Sang Eun; Kang, Ka-Won; Yi, Jun Ho; Kim, Min Kyoung; Kim, Hyo Jung; Kim, Sung-Hyun; Park, Joon Seong; Jung, Sung-Hoon; Lee, Je-Jung; Min, Chang-Ki; Lee, Jae Hoon; et al. (Cancer Research & Treatment, 2026)